Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The influence of coffee intake and genetics on adenosine pathway in rheumatoid arthritis

T. Soukup, K. Hloch, M. Doseděl, JD. Tebbens, J. Nekvindová, Š. Šembera, T. Veleta, P. Pávek, I. Barvík

. 2020 ; 21 (11) : 735-749. [pub] 20200703

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020418

Aim: We studied the influence of coffee consumption on the therapeutic effect of methotrexate (MTX) in patients with rheumatoid arthritis (RA) sorted according to ADORA2A genotypes. Patients & methods: 82 RA patients were dichotomized according to caffeine intake with a threshold of 700 mg/week. Disease activity score 28 (DAS28) was applied (>3.2: high; <3.2: low or remission). Patients were genotyped using quantitative PCR allelic discrimination. Results: We found significantly higher risk of RA in patients with higher caffeine intake and the CT genotype of ADOARA2A rs2298383, rs3761422 and rs2267076 SNPs. The CC genotype of ADORA2A rs2236624 SNP in patients with lower caffeine intake treated with MTX is significantly protective. Conclusion:ADORA2A genotypes and coffee intake influence risk of RA and efficacy of it MTX treatment.

000      
00000naa a2200000 a 4500
001      
bmc21020418
003      
CZ-PrNML
005      
20210830102119.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.2217/pgs-2020-0042 $2 doi
035    __
$a (PubMed)32615857
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Soukup, Tomáš $u 2nd Department of Internal Medicine - Gastroenterology, Division of Rheumatology, Charles University, Faculty of Medicine & University Hospital in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
245    14
$a The influence of coffee intake and genetics on adenosine pathway in rheumatoid arthritis / $c T. Soukup, K. Hloch, M. Doseděl, JD. Tebbens, J. Nekvindová, Š. Šembera, T. Veleta, P. Pávek, I. Barvík
520    9_
$a Aim: We studied the influence of coffee consumption on the therapeutic effect of methotrexate (MTX) in patients with rheumatoid arthritis (RA) sorted according to ADORA2A genotypes. Patients & methods: 82 RA patients were dichotomized according to caffeine intake with a threshold of 700 mg/week. Disease activity score 28 (DAS28) was applied (>3.2: high; <3.2: low or remission). Patients were genotyped using quantitative PCR allelic discrimination. Results: We found significantly higher risk of RA in patients with higher caffeine intake and the CT genotype of ADOARA2A rs2298383, rs3761422 and rs2267076 SNPs. The CC genotype of ADORA2A rs2236624 SNP in patients with lower caffeine intake treated with MTX is significantly protective. Conclusion:ADORA2A genotypes and coffee intake influence risk of RA and efficacy of it MTX treatment.
650    _2
$a adenosin $x genetika $x metabolismus $7 D000241
650    _2
$a dospělí $7 D000328
650    _2
$a antirevmatika $x metabolismus $x terapeutické užití $7 D018501
650    _2
$a revmatoidní artritida $x farmakoterapie $x genetika $x metabolismus $7 D001172
650    _2
$a káva $x škodlivé účinky $x metabolismus $7 D003069
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methotrexát $x metabolismus $x terapeutické užití $7 D008727
650    _2
$a lidé středního věku $7 D008875
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
650    _2
$a receptor adenosinový A2A $x genetika $7 D043705
650    _2
$a signální transdukce $x účinky léků $x fyziologie $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hloch, Karel $u Department of Social & Clinical Pharmacy, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
700    1_
$a Doseděl, Martin $u Department of Social & Clinical Pharmacy, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
700    1_
$a Tebbens, Jurjen Duintjer $u Department of Biophysics & Physical Chemistry, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
700    1_
$a Nekvindová, Jana $u University Hospital Hradec Kralove, Institute of Clinical Biochemistry and Diagnostics, Hradec Kralove, 50005, Czech Republic
700    1_
$a Šembera, Štěpán $u 2nd Department of Internal Medicine - Gastroenterology, Division of Rheumatology, Charles University, Faculty of Medicine & University Hospital in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
700    1_
$a Veleta, Tomáš $u Department of Emergency Medicine, Charles University, University Hospital in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
700    1_
$a Pávek, Petr $u Department of Pharmacology & Toxicology & Centre for Drug Development, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, 50005, Czech Republic
700    1_
$a Barvík, Ivan $u Faculty of Mathematics & Physics, Institute of Physics, Charles University, Prague, 12116, Czech Republic
773    0_
$w MED00008477 $t Pharmacogenomics $x 1744-8042 $g Roč. 21, č. 11 (2020), s. 735-749
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32615857 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102119 $b ABA008
999    __
$a ok $b bmc $g 1691068 $s 1140864
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 11 $d 735-749 $e 20200703 $i 1744-8042 $m Pharmacogenomics $n Pharmacogenomics $x MED00008477
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace